Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas.

Shindo K, Aishima S, Ohuchida K, Fujiwara K, Fujino M, Mizuuchi Y, Hattori M, Mizumoto K, Tanaka M, Oda Y.

Mol Cancer. 2013 Dec 20;12(1):168. doi: 10.1186/1476-4598-12-168.

2.

Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.

Suchanski J, Tejchman A, Zacharski M, Piotrowska A, Grzegrzolka J, Chodaczek G, Nowinska K, Rys J, Dziegiel P, Kieda C, Ugorski M.

PLoS One. 2017 Sep 22;12(9):e0184970. doi: 10.1371/journal.pone.0184970. eCollection 2017.

3.

Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment.

Suzuki S, Ishii G, Matsuwaki R, Neri S, Hashimoto H, Yamauchi C, Aokage K, Hishida T, Yoshida J, Kohno M, Nagai K, Ochiai A.

J Cancer Res Clin Oncol. 2015 Mar;141(3):475-84. doi: 10.1007/s00432-014-1851-8. Epub 2014 Oct 11.

PMID:
25304618
4.

Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.

Neri S, Ishii G, Hashimoto H, Kuwata T, Nagai K, Date H, Ochiai A.

Int J Cancer. 2015 Aug 15;137(4):784-96. doi: 10.1002/ijc.29464. Epub 2015 Feb 20.

5.

CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.

Ikenaga N, Ohuchida K, Mizumoto K, Cui L, Kayashima T, Morimatsu K, Moriyama T, Nakata K, Fujita H, Tanaka M.

Gastroenterology. 2010 Sep;139(3):1041-51, 1051.e1-8. doi: 10.1053/j.gastro.2010.05.084. Epub 2010 Jun 8.

PMID:
20685603
6.

Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.

Choi SY, Sung R, Lee SJ, Lee TG, Kim N, Yoon SM, Lee EJ, Chae HB, Youn SJ, Park SM.

J Korean Med Sci. 2013 Sep;28(9):1293-301. doi: 10.3346/jkms.2013.28.9.1293. Epub 2013 Aug 28.

7.

Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.

Pula B, Jethon A, Piotrowska A, Gomulkiewicz A, Owczarek T, Calik J, Wojnar A, Witkiewicz W, Rys J, Ugorski M, Dziegiel P, Podhorska-Okolow M.

Histopathology. 2011 Dec;59(6):1249-60. doi: 10.1111/j.1365-2559.2011.04060.x.

PMID:
22175904
8.

Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth.

Takahashi A, Ishii G, Neri S, Yoshida T, Hashimoto H, Suzuki S, Umemura S, Matsumoto S, Yoh K, Niho S, Goto K, Ohmatsu H, Nagai K, Gemma A, Ohe Y, Ochiai A.

Oncotarget. 2015 Apr 20;6(11):9531-41.

9.

Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma.

Grzegrzolka J, Wojtyra P, Biala M, Piotrowska A, Gomulkiewicz A, Rys J, Podhorska-Okolow M, Dziegiel P.

Anticancer Res. 2017 Oct;37(10):5485-5493.

PMID:
28982860
10.

Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.

Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.

Oncology. 2009;77(1):53-62. doi: 10.1159/000226112. Epub 2009 Jun 25.

PMID:
19556810
11.

CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.

Zheng B, Ohuchida K, Chijiiwa Y, Zhao M, Mizuuchi Y, Cui L, Horioka K, Ohtsuka T, Mizumoto K, Oda Y, Hashizume M, Nakamura M, Tanaka M.

Mol Carcinog. 2016 Nov;55(11):1560-1572. doi: 10.1002/mc.22409. Epub 2015 Sep 16.

PMID:
26373617
12.

Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.

Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, Shen Y, Zheng S.

Cancer Med. 2017 Feb;6(2):463-470. doi: 10.1002/cam4.993. Epub 2017 Jan 18.

13.

Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm.

Shindo K, Aishima S, Ohuchida K, Fujino M, Mizuuchi Y, Hattori M, Ohtsuka T, Tokunaga S, Mizumoto K, Tanaka M, Oda Y.

Virchows Arch. 2014 Sep;465(3):265-73. doi: 10.1007/s00428-014-1610-x. Epub 2014 Jul 3.

PMID:
24990300
14.

Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.

Goicoechea SM, García-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ, Kim HJ, Otey CA.

Oncogene. 2014 Mar 6;33(10):1265-73. doi: 10.1038/onc.2013.68. Epub 2013 Mar 25.

15.

Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.

Kawase T, Yasui Y, Nishina S, Hara Y, Yanatori I, Tomiyama Y, Nakashima Y, Yoshida K, Kishi F, Nakamura M, Hino K.

BMC Gastroenterol. 2015 Sep 2;15:109. doi: 10.1186/s12876-015-0340-0.

16.

Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.

Walter K, Omura N, Hong SM, Griffith M, Vincent A, Borges M, Goggins M.

Clin Cancer Res. 2010 Mar 15;16(6):1781-9. doi: 10.1158/1078-0432.CCR-09-1913. Epub 2010 Mar 9.

17.

Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.

Chuang WY, Yeh CJ, Chao YK, Liu YH, Chang YS, Tseng CK, Chang HK, Wan YL, Hsueh C.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):4847-56. eCollection 2014.

18.

Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.

Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J, Guo Y.

Int J Cancer. 2014 Mar 15;134(6):1369-78. doi: 10.1002/ijc.28471. Epub 2013 Oct 3.

19.

Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.

Schoppmann SF, Berghoff A, Dinhof C, Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H, Birner P.

Breast Cancer Res Treat. 2012 Jul;134(1):237-44. doi: 10.1007/s10549-012-1984-x. Epub 2012 Feb 17.

PMID:
22350732
20.

Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.

Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, Fujita H, Ohuchida K, Ohtsuka T, Takahata S, Nakamura M, Tanaka M.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9. doi: 10.1245/s10434-011-1970-2. Epub 2011 Aug 12.

PMID:
21837532

Supplemental Content

Support Center